Kiniksa Pharmaceuticals International, plc

KNSA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001730430

SEC filings (opens in a new tab)

In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Kiniksa Pharmaceuticals International, plc changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of KNSA: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Of which not filed for Q4 2022	Q4 2022	Change
Holders	104	1	125	+22
Shares	29.9M	202.6K	30.1M	+429.4K (+1.4%)
Value	$383.2M	$2.60M	$450.0M	+$69.5M (+18.3%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to KNSA in Q4 2022
Institution	Shares	Value	% of portfolio
Sphera Funds Management Ltd.	307,283	$4.60M	1.45%
Hillsdale Investment Management Inc.	244,017	$3.66M	0.31%
Healthcare of Ontario Pension Plan Trust Fund	197,800	$2.96M	0.01%
Marshall Wace, LLP	147,939	$2.22M	0.01%
AQR Capital Management LLC	145,015	$2.17M	0.00%
EAM Global Investors LLC	116,864	$1.75M	0.45%
Rafferty Asset Management, LLC	91,312	$1.37M	0.01%
EAM Investors, LLC	79,046	$1.18M	0.25%
Caxton Associates LP	66,055	$989.5K	0.07%
Jackson Creek Investment Advisors LLC	61,609	$923.0K	0.41%
Lombard Odier Asset Management (Switzerland) SA	58,832	$881.3K	0.07%
UBS Group AG	57,105	$855.4K	0.00%
Schonfeld Strategic Advisors LLC	50,000	$749.0K	0.01%
Susquehanna International Group, LLP	44,302	$663.6K	0.00%
HRT Financial LP	39,751	$595.0K	0.01%
STRS Ohio	38,100	$570.0K	0.00%
Advisory Research Inc	31,874	$477.5K	0.04%
Putnam Investments LLC	23,947	$358.7K	0.00%
Connor, Clark & Lunn Investment Management Ltd.	22,359	$334.9K	0.00%
Y-Intercept (Hong Kong) Ltd	12,920	$193.5K	0.03%
Acadian Asset Management LLC	13,014	$193.0K	0.00%
Squarepoint Ops LLC	12,163	$182.2K	0.00%
Kapitalo Investimentos Ltda	5,800	$86.9K	0.07%
Quantbot Technologies LP	5,604	$83.9K	0.01%
Lazard Asset Management LLC	4,648	$69.0K	0.00%
Altshuler Shaham Ltd	3,956	$59.3K	0.00%
Balyasny Asset Management LLC	2,695	$40.4K	0.00%
Belpointe Asset Management LLC	1,200	$18.0K	0.00%
Simplex Trading, LLC	350	$5.00K	0.00%
Advisory Services Network, LLC	100	$1.50K	0.00%

Sold out (8)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of KNSA in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
UBS Oconnor LLC	140,962	$1.81M
Jump Financial, LLC	19,400	$249.0K
XTX Topco Ltd	16,807	$216.0K
Walleye Trading LLC	15,763	$202.0K
Jane Street Group, LLC	11,194	$144.0K
Teacher Retirement System of Texas	10,105	$130.0K
Macquarie Group Ltd	4,020	$56.0K
Point72 Hong Kong Ltd	350	$4.00K

Not filed for Q4 2022 yet (1)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KNSA in Q3 2022 that haven't filed for Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Spearhead Capital Advisors, LLC	202,580	$2.60M